title: Psychologic and psychoeducational consequences of thyroxine therapy for juvenile acquired hypothyroidism.
abstract: The observation of severe behavioral reactions or learning problems in three teenagers treated with L-thyroxine for juvenile acquired hypothyroidism prompted us to conduct a prospective study of achievement and behavioral characteristics of patients with newly diagnosed juvenile acquired hypothyroidism. On diagnosis of juvenile acquired hypothyroidism and before treatment with L-thyroxine, 23 children and adolescents underwent a comprehensive battery of psychoeducational tests, which was repeated after 3, 12, and 24 months of replacement therapy. Results revealed that adverse behavioral reactions and learning problems were relatively rare in these children, although symptoms of juvenile acquired hypothyroidism were associated with increased distractibility, hyperactivity, and poorer achievement. The least gain in achievement was made by children with more severe hypothyroidism at diagnosis; children with the best psychologic outcome were those who achieved euthyroidism more slowly. We conclude that severe behavioral manifestations of L-thyroxine therapy for juvenile acquired hypothyroidism are uncommon, but mild behavioral symptoms and poorer school achievement may occur in about 25% of patients, who represent the most severe cases at diagnosis.
authors: Department of Psychology, Hospital for Sick Children, Toronto, Canada.
authors: J F
authors: JF
authors: Rovet
authors: D
authors: D
authors: Daneman
authors: J D
authors: JD
authors: Bailey
mesh_terms: D000293:Adolescent; D002648:Child; D002653:Child Behavior Disorders / Q000139:chemically induced* / Q000453:epidemiology; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology*; D015994:Incidence; D007361:Intelligence Tests; D007859:Learning Disabilities / Q000139:chemically induced* / Q000453:epidemiology; D008297:Male; D011446:Prospective Studies; D011581:Psychological Tests; D013974:Thyroxine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D013974:Thyroxine